Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vagus nerve stimulation and drug reduction.

W O Tatum1, K D Johnson, S Goff

  • 1Tampa General Hospital Comprehensive Epilepsy Center, FL, USA. WOTIV@aol.com

Neurology
|March 23, 2001
PubMed
Summary

Vagus nerve stimulation (VNS) in refractory epilepsy patients allows for significant antiepileptic drug (AED) reduction and improved patient satisfaction without compromising seizure control.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expert-Level Detection of Epilepsy Markers in EEG on Short and Long Timescales.

NEJM AI·2025
Same author

Anticipated impact of novel adult-specific pneumococcal conjugate vaccine.

Vaccine·2025
Same author

CM-Pf deep brain stimulation in polyneuromodulation for epilepsy.

Epileptic disorders : international epilepsy journal with videotape·2024
Same author

Adolescent and parental decision-making for the MenACWY vaccination: influential predictors and parental-adolescent differences among households in the Netherlands.

BMC public health·2023
Same author

Edge-Enhancing Gradient-Echo MP2RAGE for Clinical Epilepsy Imaging at 7T.

AJNR. American journal of neuroradiology·2023
Same author

Corrigendum to "Clinical utility of EEG in diagnosing and monitoring epilepsy in adults" [Clin. Neurophysiol. 129 (2018) 1056-1082].

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2022

Area of Science:

  • Neurology
  • Neurosurgery

Background:

  • Refractory epilepsy poses challenges in management.
  • Vagus nerve stimulation (VNS) is an established treatment for epilepsy.
  • Optimizing antiepileptic drug (AED) regimens is crucial for patient well-being.

Purpose of the Study:

  • To assess the feasibility of reducing antiepileptic drug (AED) burden in patients with refractory epilepsy undergoing vagus nerve stimulation (VNS).
  • To evaluate patient satisfaction levels in conjunction with AED reduction.
  • To compare outcomes with a case-matched control group.

Main Methods:

  • Prospective assessment of 21 patients with refractory epilepsy treated with VNS.
  • Comparison with a case-matched control group.
  • Mean follow-up duration of 13.2 months.

Related Experiment Videos

  • Monitoring of AED reduction and patient satisfaction.

    • Main Results:

    • 42.9% of VNS patients achieved significant AED reduction (average 0.43 AED/patient).
    • 19.0% of VNS patients experienced dose reduction.
    • Among patients not reducing AEDs, 28.6% had dose reductions.
    • No loss of seizure control was reported alongside AED modification.

    Conclusions:

    • Antiepileptic drug (AED) reduction is achievable in refractory epilepsy patients using VNS.
    • VNS facilitates AED reduction and dose modification without compromising seizure control.
    • Improved patient satisfaction is associated with AED reduction in VNS therapy.